Kala Bio (FRA:27F) Cyclically Adjusted FCF per Share: €-66.92 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:27F Kala Bio Inc FRA:27F
18 GF Score
Price €3.40
! 2 Warning Signs
View Full Analysis

What is Kala Bio Cyclically Adjusted FCF per Share?

Kala Bio FRA:27F 18 Cyclically Adjusted FCF per Share is €-66.92 as of Mar. 2026. GuruFocus rates FRA:27F with a GF Score™ of 18/100. The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Kala Bio's adjusted free cash flow per share for the three months ended in Mar. 2026 was €-10.565. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is €-66.92 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2026-07-18), Kala Bio's current stock price is €3.40. Kala Bio's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was €-66.92. Kala Bio's Cyclically Adjusted Price-to-FCF of today is .


Kala Bio  (FRA:27F) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Kala Bio Cyclically Adjusted FCF per Share Related Terms


Kala Bio Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Kala Bio's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kala Bio Cyclically Adjusted FCF per Share Chart

Kala Bio Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 -74.13

Kala Bio Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 -85.05 -74.13 -66.92

FRA:27F vs MGX, HYPD, VERU: Cyclically Adjusted FCF per Share Comparison

For the Biotechnology subindustry, Kala Bio's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kala Bio Cyclically Adjusted Price-to-FCF vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Kala Bio's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Kala Bio's Cyclically Adjusted Price-to-FCF falls into.


FRA:27F
18GF Score
Kala Bio Inc FRA:27F
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Kala Bio Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Kala Bio's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-10.565/330.2130*330.2130
=-10.565

Current CPI (Mar. 2026) = 330.2130.

Kala Bio Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201606 -932.714 241.018 -1,277.889
201609 -1,036.714 241.428 -1,417.965
201612 -992.286 241.432 -1,357.176
201703 -1,259.429 243.801 -1,705.817
201706 -878.556 244.955 -1,184.342
201709 -1,129.000 246.819 -1,510.461
201712 -578.500 246.524 -774.887
201803 -1,061.400 249.554 -1,404.458
201806 -802.300 251.989 -1,051.355
201809 -1,400.400 252.439 -1,831.850
201812 -1,142.615 251.233 -1,501.818
201903 -1,998.429 254.202 -2,595.995
201906 -1,322.786 256.143 -1,705.302
201909 -1,499.214 256.759 -1,928.111
201912 -1,182.857 256.974 -1,519.978
202003 -1,140.938 258.115 -1,459.631
202006 -802.318 257.797 -1,027.692
202009 -1,010.500 260.280 -1,282.005
202012 -943.565 260.474 -1,196.194
202103 -1,104.080 264.877 -1,376.418
202106 -700.231 271.696 -851.044
202109 -863.500 274.310 -1,039.477
202112 -1,029.429 278.802 -1,219.255
202203 -731.567 287.504 -840.242
202206 -806.967 296.311 -899.295
202209 -528.667 296.808 -588.167
202212 -405.844 296.797 -451.537
202303 -223.073 301.836 -244.045
202306 -150.167 305.109 -162.523
202309 -59.392 307.789 -63.719
202312 -130.796 306.746 -140.802
202403 -178.357 312.332 -188.568
202406 -140.885 314.175 -148.077
202409 -46.645 315.301 -48.851
202412 -47.415 315.605 -49.610
202503 -64.268 319.799 -66.361
202506 -51.577 322.561 -52.801
202509 -65.723 324.800 -66.818
202512 -6.986 324.054 -7.119
202603 -10.565 330.213 -10.565

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of €-66.92 mean?
Kala Bio (FRA:27F) has a Cyclically Adjusted FCF per Share of €-66.92 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Kala Bio and its competitors.
Is Kala Bio's Cyclically Adjusted FCF per Share too high?
Kala Bio's current Cyclically Adjusted FCF per Share is €-66.92. Overall, Kala Bio has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Kala Bio's Cyclically Adjusted FCF per Share compare to MGX and HYPD?
Kala Bio's Cyclically Adjusted FCF per Share of €-66.92 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Biotechnology company?
A good Cyclically Adjusted FCF per Share depends on the Biotechnology industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Kala Bio and its competitors. Kala Bio's current Cyclically Adjusted FCF per Share is €-66.92. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kala Bio stock overvalued right now?
Kala Bio (FRA:27F) has a current Cyclically Adjusted FCF per Share of €-66.92. The current Cyclically Adjusted FCF per Share is €-66.92. Kala Bio's overall GF Score™ is 18/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Kala Bio (FRA:27F), the current Cyclically Adjusted FCF per Share is €-66.92 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Kala Bio Business Description

Other Exchanges KALA:USA0JQ2:UK27F:Germany
Address 1167 Massachusetts Avenue, Arlington, MA, USA, 02476
Kala Bio Inc is a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of inventive therapies for rare and severe diseases of the front and back of the eye. It main product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.
18GF Score

Get the complete analysis for FRA:27F

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.40
Price